N@N

PPD Named to InformationWeek 500 List of Top Technology Innovators

^{Published on 2010-09-15 14:50:36 - Market Wire}
 

WILMINGTON, N.C.--([ BUSINESS WIRE ])--PPD, Inc. (Nasdaq: PPDI) today announced it has been named to the 2010 InformationWeek 500, an annual list of the nationa™s most innovative users of business technology. The award recognizes the companya™s strong information technology strategies, practices and investments, important areas for ensuring successful clinical research and development programs.

"For 22 years, the InformationWeek 500 has honored the most innovative users of business technology"

aTechnology is a core component of the full range of clinical development services we offer our customers, and we are pleased InformationWeek has recognized our efforts to continually improve delivery of a fully-integrated technology portfolio,a said Mike Wilkinson, executive vice president and chief information officer of PPD. aWe are focused on enabling our employees to be more effective and efficient, empowering our clients with quicker and easier access to more integrated and trusted data, and creating a superior research connection and experience for our investigative sites.a

The award was presented at a ceremony during the InformationWeek 500 Conference in Dana Point, Calif., on September 14.

PPD received the award for its Integrated and Transparent Trials initiative, a platform that provides biopharmaceutical companies a data warehouse that collects and reports data in a simple, streamlined way, giving companies faster access to trial data while creating significant cost savings.

aFor 22 years, the InformationWeek 500 has honored the most innovative users of business technology,a said Rob Preston, editor in chief of InformationWeek. aAs we start to emerge from the worst recession in decades, the IT focus is now on driving growtha"new sources of revenue, new relationships with customers, even new business models. This yeara™s ranking placed special emphasis on those companies and business technology executives leading that charge.a

The InformationWeek 500 spotlights the power of innovation in information technology, rather than identifying the biggest IT spenders. The program also tracks the technology, strategies, investments and administrative practices of Americaa™s best-known companies. For more information about the InformationWeek 500, visit [ www.informationweek.com/iw500/ ].

PPD is a leading global contract research organization, celebrating 25 years of providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 42 countries and more than 10,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit [ www.ppdi.com ].

Except for historical information, all of the statements, expectations and assumptions contained in this news release, including expectations and assumptions about the company being named to the 2010 InformationWeek 500, are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors which could cause results to differ materially include the following: the ability to attract and retain key personnel; competition within the outsourcing industry; rapid technological advances that make our products and services less competitive; success in sales growth; loss of large contracts; increased cancellation rates; economic conditions and outsourcing trends in the pharmaceutical, biotechnology, medical device, academic and government industry segments; risks associated with and dependence on collaborative relationships; risks associated with acquisitions and investments, such as impairments; risks that we may not continue our dividend policy; and the other risk factors set forth from time to time in the SEC filings for PPD, copies of which are available free of charge upon request from the PPD investor relations department.